Gertjan Wolbink
Gertjan Wolbink publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #41,767 of 7,710,434 ranked researchers
- Rank in Netherlands
- #854 of 107,149
- Works
- 329
- Citations
- 20k
- Citations per work
- 59.3
What does Gertjan Wolbink research?
Gertjan Wolbink's work is mostly in Medicine (57%), Immunology and Microbiology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences18756.8%
- Medicine18756.8%
- Everything else9428.6%
- Life Sciences4814.6%
- Immunology and Microbiology4814.6%
- 1Rheumatology35% of their works
- 2Immunology15% of their works
- 3Radiology, Nuclear Medicine and Imaging9% of their works
- 4Infectious Diseases6% of their works
- 5Genetics4% of their works
- 6Hematology3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Monoclonal and Polyclonal Antibodies Research
- Spondyloarthritis Studies and Treatments
- Biosimilars and Bioanalytical Methods
- SARS-CoV-2 and COVID-19 Research
- Chronic Lymphocytic Leukemia Research
- Immunodeficiency and Autoimmune Disorders
Which keywords describe Gertjan Wolbink's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Monoclonal Antibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Fc Receptors and Therapeutic Antibodies.
- Primary Immunodeficiency
- Genomic Aberrations
- SARS-CoV-2
- Immunogenicity
- Spondyloarthritis
- Therapeutic Antibodies
- Systemic Lupus Erythematosus
- Monoclonal Antibodies
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Antiphospholipid Syndrome
- Fc Receptors
- Ankylosing Spondylitis
- Biosimilars
- Coronavirus
- Chronic Lymphocytic Leukemia
- Genetic Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Autoantibodies2622 topics
- Inflammation1731 topic
- Rheumatoid Arthritis1731 topic
- Monoclonal Antibodies1332 topics
- Antiphospholipid Syndrome891 topic
- Systemic Lupus Erythematosus891 topic
- Fc Receptors841 topic
- Therapeutic Antibodies841 topic
- Ankylosing Spondylitis681 topic
- Spondyloarthritis681 topic
- Biosimilars491 topic
- Immunogenicity491 topic
- Coronavirus351 topic
- SARS-CoV-2351 topic
- Chronic Lymphocytic Leukemia321 topic
- Genomic Aberrations321 topic
- Genetic Mutations291 topic
- Primary Immunodeficiency291 topic
Where does Gertjan Wolbink work?
Gertjan Wolbink's main affiliation in the publication record is Sanquin, Netherlands.
How many publications and citations does Gertjan Wolbink have?
OpenAlex counts 329 works and 19,500 citations for Gertjan Wolbink, an h-index of 77, ranking #41,767 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gertjan Wolbink. Posts are plain text and can be reported.